Skip to content
Movie Casting Call
Author:
Rectify Pharmaceuticals, Inc.
Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting
August 27, 2026
Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman
July 15, 2026
Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis
May 27, 2026
Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026
May 13, 2026